← Back
$ATNF All transactions

180 Life Sciences Corp.

A

$ Value

$0

Shares

771,044

Price

$0

Filed

Aug 11

Insider

Name

Smith Ryan Lewis

Title

CIK

0001619129

Roles

Director

Transaction Details

Transaction Date

2025-08-08

Code

A

Table

Derivative

Ownership

Direct

Equity Swap

No

Shares After

771,044

Footnotes

The options were granted under the 2025 Second Supplemental Option Plan of the Issuer. The options vested immediately, but are not exercisable until stockholder approval of the 2025 Second Supplemental Option Plan is received. If stockholder approval is not received prior to August 8, 2026, the options will be cancelled. | Issued to the Reporting Person in consideration for services rendered and agreed to be rendered to the Issuer as a director of the Issuer.

Filing Info

Accession No.

0001213900-25-074501

Form Type

4

Issuer CIK

0001690080

Smith Ryan Lewis's History

Date Ticker Type Value
2026-04-02 FRMM A $0
2026-03-31 USEG $13K
2026-03-19 USEG F $20K
2026-03-04 USEG A $0
2026-02-18 ETHZ J $0
2026-02-13 USEG F $39K
2026-01-05 USEG F $21K
2025-12-01 ETHZ G $0
2025-12-01 ETHZ G $0
2025-11-14 ETHZ G $0

Other Insiders at ATNF (90d)

Insider Bought Sold Last
New Jason Griffin 2026-04-02
Rudisill McAndrew
Chief Executive Officer
2026-04-02
Smith Ryan Lewis 2026-04-02
Dalton Angela 2026-04-02
SUCKLING ANDREW P 2026-04-02
Heter Crystal Jane 2026-04-02
Saunders John Tazewell
Chief Financial Officer
2026-04-02
Edwards Michael A 2026-04-02